{"id":21570,"date":"2016-09-09T05:00:56","date_gmt":"2016-09-08T23:30:56","guid":{"rendered":"https:\/\/cardiophile.org\/?p=21570"},"modified":"2022-12-10T05:50:04","modified_gmt":"2022-12-10T00:20:04","slug":"dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\/","title":{"rendered":"DAPT Score to decide on utility of prolonged dual anti platelet therapy"},"content":{"rendered":"<p><iframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/EMNRTaWR1kc\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen=\"\"><\/iframe><\/p>\n<h2><span style=\"color: #008000;\">DAPT Score to decide on utility of prolonged dual antiplatelet therapy<\/span><\/h2>\n<p>DAPT score is based on the <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25399658\">Dual Antiplatelet Therapy Study<\/a> [1] and is used to assess the risk\/benefit ratio of prolonged dual antiplatelet therapy. <span style=\"color: #0000ff;\">Advanced age is given a negative score as it increases the bleeding risk.<\/span> Age of 75 or above is given two points while age between 65-74 years is given 1 point. Current smoking, diabetes mellitus, myocardial infarction at presentation, previous percutaneous intervention (PCI) or myocardial infarction, stent diameter of less than 3 mm and Paclitaxel eluting stent, all get 1 point each. Congestive heart failure or left ventricular ejection fraction less than 30% and saphenous vein graft PCI get 2 points each.&nbsp;If the total score is 2 or more, the benefit\/risk ratio for prolonged dual antiplatelet therapy is favourable. DAPT score below 2 is associated with an unfavourable benefit\/risk ratio.<\/p>\n<p><strong><span style=\"color: #0000ff;\">Reference<\/span><\/strong><\/p>\n<ol>\n<li>Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, Normand SL, Braunwald E, Wiviott SD, Cohen DJ, Holmes DR Jr, Krucoff MW, Hermiller J, Dauerman HL, Simon DI, Kandzari DE, Garratt KN, Lee DP, Pow TK, Ver Lee P, Rinaldi MJ, Massaro JM; DAPT Study Investigators.&nbsp;Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.&nbsp;N Engl J Med. 2014 Dec 4;371(23):2155-66.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>DAPT Score to decide on utility of prolonged dual antiplatelet therapy DAPT score is based on the Dual Antiplatelet Therapy Study [1] and is used to assess the risk\/benefit ratio of prolonged dual antiplatelet therapy. Advanced age is given a negative score as it increases the bleeding risk. Age of 75 or above is given [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":40113,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","footnotes":""},"categories":[2],"tags":[],"class_list":["post-21570","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cardiology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>DAPT Score to decide on utility of prolonged dual anti platelet therapy<\/title>\n<meta name=\"description\" content=\"DAPT score is based on the Dual Antiplatelet Therapy Study and is used to assess the risk\/benefit ratio of prolonged dual antiplatelet therapy.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"DAPT Score to decide on utility of prolonged dual anti platelet therapy\" \/>\n<meta property=\"og:description\" content=\"DAPT score is based on the Dual Antiplatelet Therapy Study and is used to assess the risk\/benefit ratio of prolonged dual antiplatelet therapy.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2016-09-08T23:30:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-12-10T00:20:04+00:00\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"DAPT Score to decide on utility of prolonged dual anti platelet therapy\",\"datePublished\":\"2016-09-08T23:30:56+00:00\",\"dateModified\":\"2022-12-10T00:20:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\\\/\"},\"wordCount\":221,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\\\/#primaryimage\"},\"thumbnailUrl\":\"\",\"articleSection\":[\"Cardiology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\\\/\",\"name\":\"DAPT Score to decide on utility of prolonged dual anti platelet therapy\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\\\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2016-09-08T23:30:56+00:00\",\"dateModified\":\"2022-12-10T00:20:04+00:00\",\"description\":\"DAPT score is based on the Dual Antiplatelet Therapy Study and is used to assess the risk\\\/benefit ratio of prolonged dual antiplatelet therapy.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\\\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"DAPT Score to decide on utility of prolonged dual anti platelet therapy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"DAPT Score to decide on utility of prolonged dual anti platelet therapy","description":"DAPT score is based on the Dual Antiplatelet Therapy Study and is used to assess the risk\/benefit ratio of prolonged dual antiplatelet therapy.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\/","og_locale":"en_US","og_type":"article","og_title":"DAPT Score to decide on utility of prolonged dual anti platelet therapy","og_description":"DAPT score is based on the Dual Antiplatelet Therapy Study and is used to assess the risk\/benefit ratio of prolonged dual antiplatelet therapy.","og_url":"https:\/\/johnsonfrancis.org\/professional\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2016-09-08T23:30:56+00:00","article_modified_time":"2022-12-10T00:20:04+00:00","author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"DAPT Score to decide on utility of prolonged dual anti platelet therapy","datePublished":"2016-09-08T23:30:56+00:00","dateModified":"2022-12-10T00:20:04+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\/"},"wordCount":221,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\/#primaryimage"},"thumbnailUrl":"","articleSection":["Cardiology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\/","url":"https:\/\/johnsonfrancis.org\/professional\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\/","name":"DAPT Score to decide on utility of prolonged dual anti platelet therapy","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\/#primaryimage"},"thumbnailUrl":"","datePublished":"2016-09-08T23:30:56+00:00","dateModified":"2022-12-10T00:20:04+00:00","description":"DAPT score is based on the Dual Antiplatelet Therapy Study and is used to assess the risk\/benefit ratio of prolonged dual antiplatelet therapy.","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/professional\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/dapt-score-to-decide-on-utility-of-prolonged-dual-anti-platelet-therapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"DAPT Score to decide on utility of prolonged dual anti platelet therapy"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/21570","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=21570"}],"version-history":[{"count":1,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/21570\/revisions"}],"predecessor-version":[{"id":57380,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/21570\/revisions\/57380"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=21570"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=21570"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=21570"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}